CMHC co-chair Christie Ballantyne, MD and Erin Michos, MD discuss the biology behind inflammation and obesity, obesity as an underappreciated but major CVD risk factor, and the ever-changing landscape of obesity treatment, with several approaches that have been recently approved or are in clinical development. They also share important practical pearls about the role of newer anti-obesity medications in conjunction with lifestyle for the long-term management of obesity.

Recorded at 2023 CMHC Spring, May 19, 2023